Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-PSMA PET/CT in Prostate Cancer Biochemical Relapse
NCT04775602Phase 2Completed
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
- Start
- Jul 2020
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 18F-PSMA in prostate cancer (PCa), sponsored by Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori". Started Jul 2020; status: completed.
02
Drugs
18F-PSMA
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04775602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04775602.